Topical antifungal treatments for tinea cruris and tinea corporis

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 8, 2014, Pages

  El Gohary, Magdy ^a   van Zuuren, Esther J ^b   Fedorowicz, Zbys ^c   Burgess, Hana ^a   Doney, Liz ^d   Stuart, Beth ^a   Moore, Michael ^a   Little, Paul ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Bahrain Branch   (Bahrain)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOROLFINE; ANTIFUNGAL AGENT; BETAMETHASONE DIPROPIONATE; BIFONAZOLE; BUTENAFINE; CICLOPIROXOLAMINE; CLOBETASOL; CLOTRIMAZOLE; EBERCONAZOLE; ECONAZOLE; FENTICONAZOLE; FLUCONAZOLE; GRISEOFULVIN; HALOPROGIN; HYDROCORTISONE; KETOCONAZOLE; LULICONAZOLE; MICONAZOLE; NAFTIFINE; OXICONAZOLE; PLACEBO; SERTACONAZOLE; SULCONAZOLE; TERBINAFINE; TETRANDRINE; TIOCONAZOLE; TOLNAFTATE; TRIAMCINOLONE ACETONIDE; UNINDEXED DRUG; WHITFIELD OINTMENT; ALLYLAMINE; BENZOIC ACID DERIVATIVE; CORTICOSTEROID; DRUG DERIVATIVE; NAPHTHALENE DERIVATIVE; PYRROLE DERIVATIVE; SALICYLIC ACID DERIVATIVE; WHITFIELD'S OINTMENT;

APPLICATION SITE ERYTHEMA; APPLICATION SITE REACTION; BURNING SENSATION; CONTACT DERMATITIS; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DRY SKIN; EDEMA; ERYTHEMA; HUMAN; MACULOPAPULAR RASH; PAPULE; PARESTHESIA; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; RECURRENT DISEASE; RELAPSE; REVIEW; SIDE EFFECT; SKIN BURNING SENSATION; SKIN FISSURE; SKIN IRRITATION; SWELLING; SYSTEMATIC REVIEW; TINEA CORPORIS; TINEA CRURIS; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; DRUG COMBINATION; FEMALE; INTRADERMAL DRUG ADMINISTRATION; MALE; META ANALYSIS; TINEA;

ADMINISTRATION, CUTANEOUS; ADRENAL CORTEX HORMONES; ALLYLAMINE; ANTIFUNGAL AGENTS; AZOLES; BENZOATES; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; NAPHTHALENES; PRURITUS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SALICYLATES; TINEA;

EID: 84907190220     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD009992.pub2     Document Type: Review

References (235)

1. Abdul Bari MA. Comparison of superficial mycosis treatment using Butenafine and Bifonazole nitrate clinical efficacy. Global Journal of Health Science 2012;5(1):150-4. [MEDLINE: 23283047]
2. Alomar C, Bassas S, Casas M, Crespo V, Ferrándiz C, Fonseca E, et al.Multi-centre double-blind trial on the efficacy and safety of sertaconazole 2% cream in comparison with miconazole 2% cream on patients suffering from cutaneous mycoses. Arzneimittel-Forschung 1992;42(5A):267-73. [MEDLINE: 1627204]
3. Altmeyer P, Nolting S, Kuhlwein A, Colli E, Scatigna M. Effect of fenticonazole spray in cutaneous mycosis: a double-blind clinical trial versus cyclopyroxolamine spray. Journal of International Medical Research 1990;18(1):61-7. [MEDLINE: 2185965]
4. Athow-Frost TA, Freeman K, Mann TA, Marks R, Vollum D, Warin AP. Clinical evaluation of fenticonazole cream in cutaneous fungal infections: a comparison with miconazole cream. Current Medical Research & Opinion 1986;10(2):107-16. [MEDLINE: 3709210]
5. Avila JM. Treatment of dermatomycoses with sulconazole 1% nitrate cream or miconazole nitrate 2% cream: a double-blind comparative study. Current Therapeutic Research 1985;38(2):328-33. [EMBASE: 1986188611]
6. Bagatell FK. A prospective study of bifonazole 1% cream in the once-daily management of tinea corporis/cruris. Advances in Therapy 1986;3(6):294-300. [EMBASE: 1987049170]
7. Banerjee M, Ghosh AK, Basak S, Das KD, Gangopadhyay DN. Comparative evaluation of effectivity and safety of topical amorolfine and clotrimazole in the treatment of tinea corporis. Indian Journal of Dermatology 2011;56(6):657-62. [MEDLINE: 22345765]
8. Banerjee M, Ghosh AK, Basak S, Das KD, Gangopadhyay DN. Comparative evaluation of efficacy and safety of topical fluconazole and clotrimazole in the treatment of tinea corporis. Journal of Pakistan Association of Dermatologists 2012;22(4):342-9. [EMBASE: 2013171467]
9. Björnberg A, Tegner E. Treatment of tinea with miconazole and miconazole-hydrocortisone. Current Therapeutic Research 1986;40(3):471-4.
10. Bogaert H, Cordero C, Ollague W, Savin RC, Shalita AR, Zaias N. Multicentre double-blind clinical trials of ciclopirox olamine cream 1% in the treatment of tinea corporis and tinea cruris. Journal of International Medical Research 1986;14(4):210-6. [MEDLINE: 3530834]
11. Borelli C, Klövekorn G, Ernst TM, Bödeker RH, Korting HC, Neumeister C. Comparative study of 2% sertaconazole solution and cream formulations in patients with tinea corporis, tinea pedis interdigitalis, or a corresponding candidosis. American Journal of Clinical Dermatology 2007;8(6):371-8. [MEDLINE: 18039020]
12. Budimulja U. Terbinafine 1% cream vs. bifonazole 1% cream in the treatment of tinea cruris. International Journal of Dermatology 1998;37(11):871-3. [MEDLINE: 9865880]
13. Budimulja U, Bramono K, Urip KS, Basuki S, Widodo G, Rapatz G, et al.Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study. Mycoses 2001;44(7-8):300-6. [MEDLINE: 11714065]
14. Califano L, Cannavo SP, Ghittoni S, Martini P, Guarneri B, Peonia G. Multicenter open randomised comparative study on efficacy and safety of topical fluconazole 0.5 % vs econazole lipogel 1% in the treatment of localised dermatomycoses [Studio multicentrico, aperto comparativo, su efficacia e tollerabilità del fluconazolo topico 0.5% vs econazolo lipogel 1% nel trattamento delle dermatomicosi con lesioni localizzate]. Giornale Italiano di Dermatologia e Venereologia 1999;134(3):263-9.
15. Clayton YM, Connor BL. Clinical trial of clotrimazole in the treatment of superficial fungal infections. Postgraduate Medical Journal 1974;50 (Suppl 1):66-9. [PUBMED: 4619461]
16. Clayton YM, Connor BL. Comparison of clotrimazole cream, Whitfield's ointment and Nystatin ointment for the topical treatment of ringworm infections, pityriasis versicolor, erythrasma and candidiasis. British Journal of Dermatology 1973;89(3):297-303. [MEDLINE: 4582719]
17. Clayton YM, Knight AG. A clinical double-blind trial of topical miconazole and clotrimazole against superficial fungal infections and erythrasma. Clinical and Experimental Dermatology 1976;1(3):225-32. [MEDLINE: 788971]
18. Clayton YM, Gange RW, Macdonald DM, Carruthers JA. A clinical double-blind trial of topical haloprogin and miconazole against superficial fungal infections. Clinical & Experimental Dermatology 1979;4(1):65-73. [MEDLINE: 376192]
19. Clayton YM, Hay RJ, McGibbon DH, Pye RJ. Double blind comparison of the efficacy of tioconazole and miconazole for the treatment of fungal infection of the skin or erythrasma. Clinical & Experimental Dermatology 1982;7(5):543-9. [MEDLINE: 6756715]
20. Clerico R, Ribuffo A. Efficacy and tolerance of fenticonazole versus miconazole cream. International Journal of Clinical Pharmacology Research 1987;7(1):77-81. [MEDLINE: 3583491]
21. Cordero C, de la Rosa I, Espinosa Z, Rojas RF, Zaias N. Short-term therapy of tinea cruris/corporis with topical terbinafine. Journal of Dermatological Treatment 1992;3 (Suppl 1):23-4. [EMBASE: 1992320846]
22. Cucè LC, Assunção BF, Medawar LG, Salibian A, Groppi W. Tolciclate versus miconazole, a double-blind trial in patients with dermatomycosis. Journal of International Medical Research 1980;8(2):144-7. [MEDLINE: 6989684]
23. del Palacio-Hernanz A, López-Gómez S, Moreno-Palancar P, González-Lastra F. A clinical double-blind trial comparing amorolfine cream 0.5% (RO-14-4767) with bifonazole cream 1% in the treatment of dermatomycoses. Clinical & Experimental Dermatology 1989;14(2):141-4. [MEDLINE: 2689018]
24. del Palacio A, Lopez S, Gimeno C, Garcia Lacalle C, Cuétara S, Garcia Bravo M. A randomized comparative study: Amorolfine (cream 0.125%, 0.25% and 0.5%) in dermatomycoses. Journal of Dermatological Treatment 1991;1(6):299-303. [EMBASE: 1991180519]
25. del Palacio A, Gip L, Bergstraesser M, Zaug M. Dose-finding study of amorolfine cream (0.125%, 0.25% and 0.5%) in the treatment of dermatomycoses. Clinical & Experimental Dermatology 1992;17(Suppl 1):50-5. [MEDLINE: 1458666]
26. del Palacio A, Cuétara S, Rodriguez Noriega A. Topical treatment of tinea corporis and tinea cruris with eberconazole (WAS 2160) cream 1% and 2%: a phase II dose-finding pilot study [Topische Behandlung der Tinea corporis und Tinea cruris mit Eberconazol (WAS 2160) 1% und 2% Creme: Eine Phase II Dosisfindungsstudie]. Mycoses 1995;38(7-8):317-24. [MEDLINE: 8559197]
27. del Palacio A, Cuétara S, Pérez A, Garau M, Calvo T, Sánchez-Alor G. Topical treatment of dermatophytosis and cutaneous candidosis with flutrimazole 1% cream: double-blind, randomized comparative trial with ketoconazole 2% cream [Topische Behandlung von Dermatophytosen und kutaner Candidose: Doppelblinde, randomisierte Vergleichsstudie mit 1%iger Flutrimazol-Creme versus 2%iger Ketoconazol-Creme]. Mycoses 1999;42(11-12):649-55. [MEDLINE: 10680442]
28. del Palacio A, Ortiz FJ, Pérez A, Pazos C, Garau M, Font E. A double-blind randomized comparative trial: eberconazole 1% cream versus clotrimazole 1% cream twice daily in Candida and dermatophyte skin infections [Eine doppelblinde, randomisierte Vergleichsstudie: Eberconazol-1%-Creme versus Clotrimazol-1%-Creme zweimaltäglich bei Candida- und Dermatophyten-Hautinfektionen]. Mycoses 2001;44(5):173-80. [MEDLINE: 11486455]
29. Dinkela A, Ferié J, Mbata M, Schmid-Grendelmeier M, Hatz C. Efficacy of triclosan soap against superficial dermatomycoses: a double-blind clinical trial in 224 primary school-children in Kilombero District, Morogoro Region, Tanzania. International Journal of Dermatology 2007;46 (Suppl 2):23-8. [MEDLINE: 17958626]
30. Dobson RL, Bagatell FK, Hickman JG, Whitmore CG, Willis I, Sefton J, et al.Naftifine 1% cream in the treatment of tinea cruris and tinea corporis. Drug Investigation 1993;3(1):57-9. [EMBASE: 1991082431]
31. Duweb GA, Hassan KA, Mahmoud GS. Topical terbinafine (Lamisil-R) cream versus clotrimazole (Micoter-R) cream in the treatment of tinea corporis. (Abstract 5237). The 19th World Congress of Dermatology 15-20 June, 1997 Sydney, Australia. Australasian Journal of Dermatology 1997;38(Suppl 2):284.
32. Effendy I, Friederich HC. Double-blind, randomized comparative study of naftifine solution (once daily) and clotrimazole solution (twice daily) in the treatment of dermatomycoses. Mykosen 1987;30(Suppl 1):104-11.
33. Evans EGV, Shah JM, Joshipura RC. One-week treatment of tinea corporis and tinea cruris with terbinafine (Lamisil) 1% cream: A placebo-controlled study. Journal of Dermatological Treatment 1992;3(4):181-4. [EMBASE: 1993020254]
34. Evans EG, James IG, Seaman RA, Richardson MD. Does naftifine have anti-inflammatory properties? A double-blind comparative study with 1% clotrimazole/1% hydrocortisone in clinically diagnosed fungal infection of the skin. British Journal of Dermatology 1993;129(4):437-42. [MEDLINE: 8217759]
35. Evans EG, Seaman RA, James IG. Short-duration therapy with terbinafine 1% cream in dermatophyte skin infections. British Journal of Dermatology 1994;130(1):83-7. [MEDLINE: 8305323]
36. Fan RQ, Liang JH, Lu YZ. Treatment of tinea cruris and candidiasis of vulva with external application of Flos Caryopyhlli and Rhizoma Coptidis Co. Journal of Guangzhou University of Traditional Chinese Medicine (Guang Zhou Zhong Yi Xue Yuan Xue Bao) 1991;8(2-3):170-5.
37. Fan RQ, Yang YL. Clinical observation on the effect of Xianglian Fufang preparation for pityriasis versicolor, tinea corporis and cruris. Chinese Journal of Integrated Traditional and Western Medicine (Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi) 1994;14(10):614-5.
38. Finzi A, Fiorini A, Monici Preti P, Mounari M. A double blind evaluation of fenticonazole cream 2% and clotrimazole cream 1% in dermatomycoses [Doppelblindstudie mit Fenticonazol-Creme 2%ig un Clotrimazol-Creme 1% bei Dermatomykosen]. Mykosen 1986;29(1):41-4. [MEDLINE: 3515169]
39. Fredriksson T. Treatment of dermatomycoses with topical tioconazole and miconazole. Dermatologica 1983;166 (Suppl 1):14-9. [MEDLINE: 6350071]
40. Friederich HC, Haas PJ, Tronnier H, Weidinger G. Comparison of treatment with naftifine and with a combination of a corticosteroid and an imidazole derivative [Entzündlichen Dermatomykosen. Therapie Vergleich zwischen Naftifine und einem corticosteroid hältigen Imidazole-Derivat]. Aktuelle Dermatologie 1985;11:77-80.
41. Fulton JE. Miconazole therapy for endemic fungal disease. Archives of Dermatology 1975;111(5):596-8. [MEDLINE: 1093481]
42. Ghaninejad H, Gholami K, Hashemi P, Hajibabai M, Rahbar Z, Farivar MS, et al.Sertaconazole 2% cream vs. miconazole 2% cream for cutaneous mycoses: a double-blind clinical trial. Clinical & Experimental Dermatology 2009;34(8):e837-9. [MEDLINE: 19793095]
43. Gip L, Langen ML. Results of a contralateral comparative study between Travocort cream and Travogen cream in inflammatory and allergic dermatomycoses [Ergebnisse eines Halbseitenvergleichs zwischen Travocort Creme und Travogen Creme bei entzündlichen und ekzematisierten Dermatomykosen]. Mykosen 1980;23(2):79-84. [MEDLINE: 6991938]
44. Gip L, Forsström S. A double-blind parallel study of sulconazole nitrate 1% cream compared with miconazole nitrate 2% cream in dermatomycoses [Eine parallele Doppelblinstudie mit 1%iger Sulconazol-nitratcreme und 2%iger Miconazol-nitratcreme bei Dermatophytosen]. Mykosen 1983;26(5):231-41. [MEDLINE: 6877272]
45. Gip L. Comparison of oxiconazole (Ro-13-8996) and econazole in dermatomycoses [Vergleich von Oxiconazol und Econazol (Ro-13-8996) bei Dermatomykosen]. Mykosen 1984;27(6):295-302. [MEDLINE: 6382000]
46. Gip L, Brundin G. A double-blind, two group multicentre study, comparing naftifine 1% cream with placebo cream in the treatment of tinea cruris. Mykosen 1987;30(Suppl 1):38-41.
47. Gong KM, Shi HJ. The report of 2% ketoconazole for skin ringworm (Chinese). Chinese Journal of Dermatovenereology 1991;5(4):253.
48. Greer DL, Jolly HW. Treatment of tinea cruris with topical terbinafine. Journal of the American Academy of Dermatology 1990;23(4 Pt 2):800-4. [MEDLINE: 2229527]
49. Greer DL, Weiss J, Rodriguez DA, Hebert AA, Swinehart, JM. A randomized trial to assess once-daily topical treatment of tinea corporis with butenafine, a new antifungal agent. Journal of the American Academy of Dermatology 1997;32(2 Pt 1):231-5. [MEDLINE: 9270509]
50. Grigoriu D, Grigoriu A. Double-blind comparison of the efficacy, toleration and safety of tioconazole base 1% and econazole nitrate 1% creams in the treatment of patients with fungal infections of the skin or erythrasma. Dermatologica 1983;166(Suppl 1):8-13. [MEDLINE: 6350072]
51. Guillano GJ, Alabado KLP. A randomized, double-blind, clinical trial on the effectiveness and safety of 50% Gliricidia sepium (Kakawate/Madre de Cacao) ointment compared with 2% miconazole ointment in the treatment of tinea corporis and tinea cruris (a pilot study). Journal of the Philippine Dermatological Society 2005;14(2):15-22.
52. Hall-Smith P. Dermatomycoses: a brief history of therapy and initial results with clotrimazole. Postgraduate Medical Journal 1974;50 (Suppl 1):70-2. [MEDLINE: 4619462]
53. Hantschke D, Reichenberger M. Double-blind, randomised in vivo investigations comparing the antifungals clotrimazole, tolnaftate and naftifine [Doppelblinde, Randomisierte vergleichende in vivo Untersuchungen zwischen den Antimykotika Clotrimazol, Tolnaftat und Naftifin]. Mykosen 1980;23(12):657-68.
54. Haroon TS, Hussain I, Aman S, Jahangir M. Randomized, comparative, study of 1% naftifine cream (once daily) and 1% tioconazole cream (twice daily) in the treatment of tinea cruris. Specialist. Pakistan Journal of Medical Sciences Quarterly 1996;12(2):181-4. [EMBASE: 1996115554]
55. Holti G. A double blind, controlled trial of Whitfield's ointment and Variotin in ringworm infections with a 2 year "follow-up". Acta Dermato-Venereologica 1970;50:229-31. [MEDLINE: 4193225]
56. Jerajani HR, Janaki C, Kumar S, Phiske M. Comparative assessment of the efficacy and safety of sertaconazole (2%) cream versus terbinafine (1%) cream versus luliconazole (1%) cream in patients with dermatophytoses: A pilot study. Indian Journal of Dermatology 2013;58(1):34-8. [MEDLINE: 23372210]
57. Jordon RE, Rapini RP, Rex IH Jr, Katz HI, Hickman JG, Bard JW, et al.Once-daily naftifine cream 1% in the treatment of tinea cruris and tinea corporis. International Journal of Dermatology 1990;29(6):441-2. [MEDLINE: 2397973]
58. Jung EG, Bisco A, Azzollini E, Sartani A, Ruffmann R. Fenticonazole cream once daily in dermatomycosis, a double-blind controlled trial versus bifonazole. Dermatologica 1988;177(2):104-8. [MEDLINE: 3049173]
59. Kagawa S. Comparative clinical trial of naftifine and clotrimazole in tinea pedum, tinea cruris and tinea corporis. Mykosen 1987;30(Suppl 1):63-9.
60. Kalis B, Grosshans E, Binet O, Garrel JB, Grossetête G, Jeanpierre G, et al.Oxiconazole cream versus ketoconazole cream: A prospective, randomized, double-blind multicentric study in the treatment of tinea cruris [Oxiconazole crème versus kétoconazole crème. Etude prospective, randomisée, en double-insu, multicentrique, dans le traitement des dermatophytoses inguinocrurales]. Annales de Dermatologie et de Venereologie 1996;123(8):447-52. [EMBASE: 1996268459]
61. Kashin P, Phyfferoen MC, Gibbs DL. A comparative study of once versus twice daily treatment of superficial dermatophyte and yeast infections with tioconazole (1%) cream. Journal of International Medical Research 1985;13(2):88-95. [MEDLINE: 3888731]
62. Katz R, Cahn B. Haloprogin therapy for dermatophyte infections. Archives of Dermatology 1972;106(6):837-8. [MEDLINE: 4565228]
63. Katz HI, Bard J, Cole GW, Fischer S, McCormick GE, Medansky RS, et al.SCH 370 (clotrimazole-betamethasone dipropionate) cream in patients with tinea cruris or tinea corporis. Cutis 1984;34(2):183-8. [MEDLINE: 6383734]
64. Keczkes K, Leighton I, Good CS. Topical treatment of dermatophytoses and candidoses. Practitioner 1975;214(1281):412-7.
65. Kokoschka EM, Niebauer G, Mounari M, Monici Preti P. Treatment of dermatomycoses with topical fenticonazole and econazole [Lokalbehandlung von Dermatomykosen mit fenticonazol und econazol]. Mykosen 1986;29(1):45-50. [MEDLINE: 3515170]
66. Kuhlwein A, Busch T. No English Title [Tinea inguinalis und tinea pedis: cruconazol versus bifonazol in der Lokaltherapie]. Therapiewoche 1990;40:1643-5.
67. Lassus A, Forström S, Salo O. A double-blind comparison of sulconazole nitrate 1% cream with clotrimazole 1% cream in the treatment of dermatophytoses. British Journal of Dermatology 1983;108(2):195-8. [MEDLINE: 6337618]
68. Lassus A, Forsström S. A double-blind parallel study comparing sulconazole with econazole in the treatment of dermatophytoses [Eine vergleichende Doppelblindstudie mit Sulconazol und Econazol in der Behandlung von Dermatophytosen]. Mykosen 1984;27(12):592-8. [MEDLINE: 6395015]
69. Lassus A, Nolting KS, Savopoulos C. Comparison of ciclopirox olamine 1% cream with ciclopirox 1%-hydrocortisone acetate 1% cream in the treatment of inflamed superficial mycoses. Clinical Therapeutics 1988;10(5):594-9. [MEDLINE: 2856602]
70. Lebwohl M, Foged EK, Karvonen J, James IG, Grosshans E, van Heerden JS, et al.Terbinafine (1%) solution and emulsion gel: two new formulations in one week treatment of tinea pedis and tinea corporis/cruris (Abstract P218). The 7th Congress of the European Academy of Dermatology and Venereology, Nice, 7-11 Ocober 1998. Journal of the European Academy of Dermatology & Venereology 1998;11(Suppl 2):S237.
71. Lebwohl M, Elewski B, Eisen D, Savin RC. Efficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea pedis and tinea corporis or tinea cruris. Cutis 2001;67(3):261-6. [PUBMED: 11270304]
72. Ledezma E, López JC, Marin P, Romero H, Ferrara G, De Sousa L, et al.Ajoene in the topical short-term treatment of tinea cruris and tinea corporis in humans. Randomized comparative study with terbinafine. Arzneimittel-Forschung 1999;49(6):544-7. [MEDLINE: 10417874]
73. Leiste D, Braun W, Fegeler W, Fegeler K, Stary A, Ruping KW, et al.A double-blind clinical trial of fenticonazole (2%) spray versus naftifine (1%) spray in patients with cutaneous mycoses. Current Medical Research & Opinion 1989;11(9):567-75. [MEDLINE: 2692971]
74. Lesher JL, Babel DE, Stewart DM, Jones TM, Kaminester L, Goldman M, et al.Butenafine 1% cream in the treatment of tinea cruris: a multicenter, vehicle-controlled, double-blind trial. Journal of the American Academy of Dermatology 1997;36(2 Pt 1):S20-4. [MEDLINE: 9039201]
75. Li R, Liu W, Zeng F, Wang A. Assessment of the efficacy and safety of amorolfine cream vs. bifonazole cream, in the treatment of tinea corporis/cruris (Abstract P22-15). The 12th Congress of the European Academy of Dermatology and Venereology. Barcelona, Spain 15-18th October 2003. Journal of the European Academy of Dermatology & Venereology 2003;17(Suppl3):319.
76. Li Q, Li M, Jin L, Qin LM, Gu J, Liu WD, et al.Clinical efficacy of compound econazole cream in treatment of tinea corporis, tinea inguinalis, tinea manus, tinea pedis and its safety. Pharmaceutical Care & Research (Yaoxue Fuwu Yu Yanjiu) 2004;4(1):52-4. [EMBASE: 2004249361]
77. Li M, Bi ZG, Gu J, Sheng YN, Zhang MH, Wang Y, et al.Clinical study of butenafine hydrochloride 1% cream in the treatment of tinea pedis, tinea corporis and tinea cruris. Journal of Clinical Dermatology 2006;35(7):471-2. [EMBASE: 2006426871]
78. Luciani P, Barba A. Double blind comparative study of 1% econazole cream and 1% bifonazole cream in the treatment of dermatomycoses [Studio comparativo in doppio cieco fra econazolo crema 1% e bifonazolo crema 1% nel trattamento delle dermatomicosi]. Giornale Italiano di Dermatologia e Venereologia 1988;123(10):LIII-LVI. [MEDLINE: 3248815]
79. Macasaet EN, Pert P. Topical (1%) solution of griseofulvin in the treatment of tinea corporis. British Journal of Dermatology 1991;124(1):110-1. [MEDLINE: 1993136]
80. Machado-Pinto J, Laborne MS. The use of oxiconazole 1% cream in the treatment of dermatophytoses [Uso do creme de oxiconazol a 1% no tratamento de dermatofitoses]. A Folha Médica 1987;95(5-6):381-4.
81. McVie DH, Littlewood S, Allen BR, Pollock AC, Wood P, Milne LJ. Sulconazole versus clotrimazole in the treatment of dermatophytosis. Clinical & Experimental Dermatology 1986;11(6):613-8. [MEDLINE: 3311492]
82. Meinicke K, Striegel C, Weidinger G. Treatment of dermatomycoses with naftifine therapeutic efficacy on application once daily and twice daily. Mykosen 1987;30(Suppl 1):98-103.
83. Meinicke K, Striegel C, Weidinger G. Treatment of dermatomycosis with Naftifin. Therapeutic effectiveness following once and twice daily administration [Dermatomykosebehandlung mit Naftifin. Therapeutische Wirksamkeit nach einmal und zweimal täglicher Applikation]. Mykosen 1984;27(12):608-14. [PUBMED: 6395017]
84. Mertens RL, Morias J, Verhamme G. A double-blind study comparing Daktacort, miconazole and hydrocortisone in inflammatory skin infections. Dermatologica 1976;153(4):228-35. [MEDLINE: 797593]
85. Millikan LE, Galen WK, Gewirtzman GB, Horwitz SN, Landow RK, Nesbitt LT Jr, et al.Naftifine cream 1% versus econazole cream 1% in the treatment of tinea cruris and tinea corporis. Journal of the American Academy of Dermatology 1988;18(1 Pt 1):52-6. [MEDLINE: 3279083]
86. Millikan LE. Efficacy and tolerability of topical terbinafine in the treatment of tinea cruris. Journal of the American Academy of Dermatology 1990;23(4 Pt 2):795-9. [MEDLINE: 2229526]
87. Miura Y, Onuki M, Takahashi S, Seiji M, Sato A, Kagawa S, et al.A double-blind study on utility of econazole cream in dermatomycosis. Rinsho Hyoka (Clinical Evaluation) 1979;7(1):83-108.
88. Nolting S, Langen ML. Are topical corticosteroids advantageous and justifiable in the treatment of dermatomycoses (Travocort® cream and Travogen® cream were compared in 100 patients in an inter-individual double-blind trial [Ist der Einsatz von Kortikosteroiden in der Therapie von Dermatomykosen sinnvoll? (Travocort® Creme und Travogen® Creme im interindividuellen Vergleich an 100 Patienten)]. Mykosen 1980;23(12):699-706.
89. Nolting S, Weidinger G. Naftifine in severe dermatomycoses: econazole-controlled therapeutic comparison. Mykosen 1987;30(Suppl 1):70-7.
90. Nolting S, Weidinger G. Naftifine in severe dermatomycosis-econazole-controlled therapeutic comparison [Naftifin bei schweren Dermatomykosen-Kontrollierter Wirkungsvergleich mit Econazol]. Mykosen 1985;28(2):69-76. [EMBASE: 1985082732]
91. Nolting S. Double-blind, randomized study comparing three concentrations (0.125%, 0.25%, 0.5%) of RO-14- 4767 and bifonazole 1% in patients with dermatomycoses. Congress of the International Society for Human and Animal Mycology. Barcelona, 1988:19.
92. Nolting S, Semig G, Friedrich HK, Dietz M, Reckers-Czaschka R, Bergstraesser M, et al.Double-blind comparison of amorolfine and bifonazole in the treatment of dermatomycoses. Clinical & Experimental Dermatology 1992;17(Suppl 1):56-60. [MEDLINE: 1458667]
93. Nuñez CR. Treatment of dermatomycoses with sulconazole nitrate 1% cream or econazole nitrate 1% cream: a double-blind comparative study. Advances in Therapy 1985;2(3):112-7. [EMBASE: 1985162144]
94. Oladele AT, Dairo BA, Elujoba AA, Oyelami AO. Management of superficial fungal infections with Senna alata ("alata") soap: A preliminary report. African Journal of Pharmacy & Pharmacology 2010;4(3):98-103. [EMBASE: 2010236028]
95. Pariser RJ, Pariser DM, Caro E, Gomez C, Lazan DW, Martin S, et al.Clinical and mycological effect of clotrimazole/betamethasone dipropionate cream versus ketoconazole cream in patients with tinea cruris. Journal of Dermatological Treatment 1995;6(3):173-7. [EMBASE: 1995319730]
96. Parish LC, Parish JL, Routh HB, Avakian E, Olayinka B, Pappert EJ, et al.A double-blind, randomized, vehicle-controlled study evaluating the efficacy and safety of naftifine 2% cream in tinea cruris. Journal of Drugs in Dermatology 2011;10(10):1142-7. [MEDLINE: 21968664]
97. Qadripur SA. Double-blind parallel comparison of sulconazole nitrate, 1% cream and powder, with econazole, 1% cream and powder, in the treatment of cutaneous dermatophytoses. Current Therapeutic Research 1984;35(5):753-8. [EMBASE: 1985078201]
98. Ramam M, Prasad HR, Manchanda Y, Khaitan BK, Banerjee U, Mukhopadhyaya A, et al.Randomised controlled trial of topical butenafine in tinea cruris and tinea corporis. Indian Journal of Dermatology, Venereology & Leprology 2003;69(2):154-8. [MEDLINE: 17642865]
99. Ramalet A, Walker-Nasir E. Oxiconazole cream: a comparison of two treatment schedules. Chemioterapia 1987;6(2 Suppl):542-4. [PUBMED: 3334619]
100. Ramelet AA, Walker-Nasir E. One daily application of oxiconazole cream is sufficient for treating dermatomycoses. Dermatologica 1987;175(6):293-5. [MEDLINE: 3319722]
101. Repiso Montero T, López S, Rodríguez C, del Rio R, Badell A, Gratacós MR. Eberconazole 1% cream is an effective and safe alternative for dermatophytosis treatment: multicenter, randomized, double-blind, comparative trial with miconazole 2% cream. International Journal of Dermatology 2006;45(5):600-4. [MEDLINE: 16700802]
102. Schwarz KJ, Luggen H, Banninger R, Konzelmann M. Tests with Pevisone in outpatients: double-blind study including 101 patients [Poliklinische Prüfung von Pevisone: Doppelblindstudie an 101 Patienten]. Praxis 1978;67(30):1112-6. [MEDLINE: 674089]
103. Sehgal VN. Ciclopirox: a new topical pyrodonium antimycotic agent. A double blind study in superficial dermatomycoses. British Journal of Dermatology 1976;95(1):83-8. [MEDLINE: 782504]
104. Sharma A, Saple DG, Surjushe A, Rao GRR, Kura M, Ghosh S, et al.Efficacy and tolerability of sertaconazole nitrate 2% cream vs. miconazole in patients with cutaneous dermatophytosis. Mycoses 2011;54(3):217-22. [MEDLINE: 19925567]
105. Shen WM, Hu YW, Gu HY. Econazole compound cream vs miconazole cream in treating tinea corporis & cruris. Chinese Journal of New Drugs and Clinical Remedies 2002;21(3):143-5.
106. Shi JP, Zhang H, Zhang ZD, Zhang GH, Gao AL, Xiang SB. Synergistic effects of tetrandrine on the antifungal activity of topical ketoconazole cream in the treatment of dermatophytoses: a clinical trial. Chinese Journal of Integrative Medicine 2011;17(7):499-504. [MEDLINE: 21725874]
107. Singal A, Pandhi D, Agrawal S, Das S. Comparative efficacy of topical 1% butenafine and 1% clotrimazole in tinea cruris and tinea corporis: a randomized, double-blind trial. Journal of Dermatological Treatment 2005;16(5-6):331-5. [MEDLINE: 16428155]
108. Sivayathorn A, Piamphongsant T. Topical antimycotic agents for the treatment of superficial dermatophytoses in Thailand - A double-blind study [Lokal wirksame Antimykotika für die Behandlung oberflächlicher Dermatophytosen in Thailand - Eine doppfelblinde Studie]. Mykosen 1979;22(1):21-4. [MEDLINE: 368628]
109. Smith EB, David LM, Knox JM. Topical clotrimazole in dermatophytosis in a prison environment. Postgraduate Medical Journal 1974;50(Suppl 1):64-6. [MEDLINE: 4619460]
110. Spiekermann PH, Young MD. Clinical evaluation of clotrimazole. A broad-spectrum antifungal agent. Archives of Dermatology 1976;112(3):350-2. [MEDLINE: 769697]
111. Su, JG, Pan XF. The curative effect observation of compound miconazole cream in treating tinea cruris. Chinese Journal of Dermatovenereology 2001;15(5):357.
112. Susilo R, Korting HC, Strauss UP, Sertaconazole Study Group. Dermatomycoses of the glabrous skin: a double-blind, randomised, comparative trial of sertaconazole 2% cream once daily versus vehicle. Clinical Drug Investigation 2003;23(6):387-94. [MEDLINE: 17535049]
113. Tanenbaum L, Anderson C, Rosenberg MJ, Howard W, McDaniel W, Neimanis A, et al.Sulconazole nitrate 1.0 percent cream: a comparison with miconazole in the treatment of tinea pedis and tinea cruris/corporis. Cutis 1982;30(1):105-7. [MEDLINE: 6749440]
114. Tanenbaum L, Taplin D, Lavelle C, Akers WA, Rosenberg MJ, Carmargo G. Sulconazole nitrate cream 1 percent for treating tinea cruris and corporis. Cutis 1989;44(4):344-7. [MEDLINE: 2805811]
115. Thomas DJ. A study in industry of clotrimazole cream in tinea pedis and tinea cruris. Current Medical Research & Opinion 1976;3(9):630-3. [EMBASE: 0977017004]
116. Thomas DJ, Evans A. A study in industry of bifonazole (1% gel) and sulconazole cream in tinea pedis and tinea cruris. In: Hay RJ editor(s). Advances in Topical Antifungal Therapy. Berlin: Springer-Verlag, 1986:68-75.
117. Thulin H, Østerbye P. Miconazole in the treatment of dermatomycosis. Mykosen 1975;18(5):249-53. [MEDLINE: 1160934]
118. Tronnier H. Inflammatory dermatomycoses -comparative study of naftifine and a combination of a corticosteroid and an imidazole derivative. Mykosen 1987;30(Suppl 1):78-87.
119. Vander Ploeg DE, De Villez RL. A new topical antifungal drug: tioconazole. International Journal of Dermatology 1984;23(10):681-3. [MEDLINE: 6396247]
120. VanDersarl JV, Sheppard RH. Clotrimazole vs haloprogin treatment of tinea cruris. Archives of Dermatology 1977;113(9):1233-5. [MEDLINE: 578400]
121. van Heerden JS, Vismer HF. Tinea corporis/cruris: new treatment options. Dermatology 1997;194(Suppl 1):14-8. [MEDLINE: 9154395]
122. Vannini P, Difonzo EM, Cordaro CI, Sartani A, Panconesi E. New therapeutic approach in skin mycoses: a comparative trial once versus twice daily applications of fenticonazole in comparison to miconazole [Neuer Therapieansatz bei Hautmykosen: Studie über die tägliche Einmal- und Zweimal-anwendung von Fenticonazol im Vergleich mit Miconazol]. Mycoses 1988;31(5):280-4.
123. Vena GA, Barile F, Faravelli M, Angelini G. Efficacy and safety of bifonazole (BAY h 4502) in patients with pityriasis versicolor and tinea cruris [Zur Wirkzamkeit und Verträglichkeit von Bifonazol (BAY h 4502) bei Patienten mit Pityriasis versicolor und Tinea inguinalis]. Mykosen 1983;26(8):415-20. [MEDLINE: 6621617]
124. Viayna C, Álvarez D, Domper N, Puerta L, Martínez D, López R. Eberconazole 1% cream in the treatment of dermatophytosis: double-blind, randomised comparative trial with miconazole 2% cream (Abstract FC1-10). The 12th Congress of the European Academy of Dermatology and Venereology. Barcelona, Spain15-18th October. Journal of the European Academy of Dermatology & Venereology 2003;17(Suppl 3):14.
125. Voravutinon V. A randomized comparative study in treatment of tinea corporis, tinea cruris with whitfield's ointment and miconazole cream. Thai Journal of Dermatology 1993;9(1):1-10.
126. Wagner W, Reckers-Czaschka R. Oxiconazole in dermatomycosis -a double-blind, randomized comparison with bifonazole [Oxiconazol bei Dermatomykosen - ein Doppelblinder, randomisierter Therapievergleich mit Bifonazol]. Mykosen 1987;30(10):484-92. [PUBMED: 3325843]
127. Wang AP, Li ZY, Wang DL, Ma SQ, Zhou ZD, Wan Z. The clinical Lamisil cream for body and tinea cruris (Chinese). Journal of Clinical Dermatology 1995;24(2):100-1.
128. Wang KY, Li CY, Liang LP. A randomized controlled clinical study of terbinafine powder versus miconazole for the treatment of tinea manum/pedis and tinea corporis/cruris. Chinese Journal of Clinical Pharmacology 2000;16(4):265-8.
129. Wang AP, Li RY, Shun QN, Wan Z, Wang XH, Wang JB, et al.A double blind randomized controlled clinical trial of econazole-triamcinolon acetonide cream in the treatment of tinea pedis and tinea corporis & cruris. Chinese Journal of Clinical Pharmacology 2000;16(5):345-9.
130. Weitgasser H. Clinical and myocological study of the antifungal agent haloprogin [Klinische und mykologische Untersuchungen mit dem Antimykotikum Haloprogin]. Mykosen 1977;20(1):15-24. [MEDLINE: 321954]
131. Wortzel MH. A double-blind study comparing the superiority of a combination antifungal (clotrimazole)/steroidal (betamethasone dipropionate) product. Cutis 1982;30(2):258-61. [MEDLINE: 6751707]
132. Yim SM, Ko JH, Lee YW, Kim HW, Lee JY, Kim NI, et al.Study to compare the efficacy and safety of fluconazole cream with flutrimazole cream in the treatment of superficial mycosis: a multicentre, randomised, double-blind, phase III trial. Mycoses 2010;53(6):522-9. [MEDLINE: 19558428]
133. Zaias N, Berman B, Cordero CN, Hernandez A, Jacobson C, Millikan L, et al.Efficacy of a 1-week, once-daily regimen of terbinafine 1% cream in the treatment of tinea cruris and tinea corporis. Journal of the American Academy of Dermatology 1993;29(4):646-8. [MEDLINE: 8408803]
134. Zarowny DP, Rogers RS, Tindall JP. Evaluation of the effectiveness of griseofulvin, tolnaftate, and placebo in the topical therapy of superficial dermatophytoses. Journal of Investigative Dermatology 1975;64(4):268-72. [MEDLINE: 1090684]
135. Zaun H, Luszpinski P. Antifungal treatment of hospital inpatients -'left versus right' study to compare naftifine and clotrimazole. Mykosen 1987;30(Suppl 1):42-8.
136. Zaun H, Luszpinski P. Multicenter double-blind contralateral comparison of naftifin and clotrimazole cream in patients with dermatophytosis and candidiasis [Multizentrischer doppelblinder Halbseitenvergleich von naftifin-und clotrimazol-Creme bei Patienten mit Dermatophytosen und Candidosen]. Zeitschrift für Hautkrankheiten 1984;59(18):1209-17. [PUBMED: 6388169]
137. Anderson BJ. Effectiveness of body wipes as an adjunct to reducing skin infections in high school wrestlers. Clinical Journal of Sport Medicine 2012;22(5):424-9. [MEDLINE: 22695403]
138. Arnoldi EG. Clinical trial with tolnaftate in the treatment of superficial mycosis [Estudio clínico com o tolnaftato no tratamento das micoses superficiais]. Revista Brasileira de Clínica e Terapêutica 1979;8(7):316-8. [EMBASE: 1980169707]
139. Arreaza de Arreaza F, Díaz de Torres E, Briceño Maaz T. Double-blind comparative study of RO-13-8996 with miconazole in relation to its efficiency and local tolerance in patients with dermatomycosis [Estudio comparativo doble ciego de RO-13-8996 con miconazole en relación a sus eficacia y tolerancia local en pacientes con dermatomicosis]. Medicina Cutánea Ibero Latino Americana 1984;12(1):57-61. [MEDLINE: 6376980]
140. Baran R, Beurey J, Civatte J, Desmons F, Hincky M, Meynadier J, et al.Multicentric clinical trial of a new combination of a broad spectrum antimycotic and a dermocorticoid [Étude thérapeutique multicentrique d'une nouvelle association d'un antifongique a large spectre et d'un corticoïde]. La Semaine des Hôpiteaux 1979;55(5-6):269-72. [MEDLINE: 219539]
141. Bonifaz A, Saul A. Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis. European Journal of Dermatology 2000;10(2):107-9. [MEDLINE: 10694308]
142. Comaish JS. Double blind comparison of clotrimazole with Whitfield's and nystatin ointments. Postgraduate Medical Journal 1974;50(Suppl 1):73-5. [MEDLINE: 4619463]
143. Darouti MA, Kalinka P. Naftifine cream 1% compared with miconazole cream 2% in dermatophytosis. International Journal of Dermatology 1990;29(7):521-2. [MEDLINE: 2228386]
144. Fiorini JE, Fiorini CM, Pedreira RC, de Faria-e-Silva PM, Chavasco JK. Topical application of isoconazole in the superficial mycosis treatment [Aplicação tópica do nitrato de isoconazol para o tratamento de micoses superficiais]. Revista Brasileira de Medicina 1991;48(6):344, 346-7, 349-50. [EMBASE: 1991251687]
145. Hay RJ, Clayton YM, Griffiths WA, Dowd PM. A comparative double blind study of ketoconazole and griseofulvin in dermatophytosis. British Journal of Dermatology 1985;112(6):691-6. [MEDLINE: 3890924]
146. Kagawa S. Clinical efficacy of terbinafine in 629 Japanese patients with dermatomycosis. Clinical and Experimental Dermatology 1989;14(2):114-5. [MEDLINE: 2689013]
147. Kamalam A, Thambiah AS. Clotrimazole and econazole in dermatophytoses (a double-blind study) [Clotimazol und Econazol bei Dermatomykosen]. Mykosen 1980;23(12):707-10. [MEDLINE: 7012613]
148. László A, Balogh G, Kohányi E, Román S. Use of Nizoral cream in dermatomycoses. Therapia Hungarica 1991;39(4):179-82. [MEDLINE: 1811329]
149. Mathur SM, Agarwal RK. Clinical trial of 'Jadit' in superficial mycoses. Indian Journal of Dermatology, Venereology, & Leprology 1973;39(6):266-9. [EMBASE: 0974199232]
150. Nada M, Hanafi S, al-Omari H, Mokhtar M, el-Shamy S, Mühlbacher J. Naftifine versus miconazole/hydrocortisone in inflammatory dermatophyte infections. International Journal of Dermatology 1994;33(8):570-2. [MEDLINE: 7960355]
151. Turkish Multicenter Dermatophytosis Study Group. Naftifine treatment for dermatophytosis: multicenter clinical investigations in Turkey. International Journal of Dermatology 1992;31(4):247-8. [MEDLINE: 1503576]
152. Saple DG, Amar AK, Ravichandran G, Korde KM, Desai A. Efficacy and safety of butenafine in superficial dermatophytoses (tinea pedis, tinea cruris, tinea corporis). Journal of the Indian Medical Association 2001;99(5):274-5. [MEDLINE: 11676116]
153. Sartani A, Cordaro CI, Panconesi E. A multicenter trial with a new imidazole derivative, fenticonazole, in superficial fungal skin infections. Current Therapeutic Research 1988;43(6):1194-1203. [EMBASE: 1988173204]
154. Scherwitz C. Clinical testing of Econazole skin lotion and cream in dermatomycoses [Klinische Prüfung von Econazol Haut-Milch und - Creme bei Hautmykosen]. Zeitschrift für Hautkrankheiten 1977;52(4):117-25. [MEDLINE: 842066]
155. Svejgaard E. Double blind trial of miconazole in dermatomycosis. Acta Dermato-Venereologica 1973;53(6):497-500. [EMBASE: 0974120905]
156. Szarmach H, Weuta H, Stepka L. Limitations of indications of clotrimazole-hydrocortisone and its components. A double-blind study [Indikationsabgrenzung zwischen Clotrimazol/Hydrocortison und seinen beiden Komponenten: Eine Doppelblinde Studie]. Arzneimittel-Forschung 1984;34(8):927-30. [PUBMED: 6388585]
157. Török I, Stehlich G. Double-blind comparative examination of ketoconazole 1% cream and clotrimazole 2% ointment in superficial dermatomycosis. Therapia Hungarica 1993;41(2):60-3. [MEDLINE: 8278940]
158. Tulli A. Evaluation of the clinical efficacy and tolerance of a formulation of 2% tioconazole cream versus 1% tioconazole cream in the treatment of dermatomycoses [Valutazione dell'efficacia clinica e della tollerabilità di una formuliazione di tioconazolo crema 2% vs tioconazolo crema 1% nella terapia delle dermatomicosi]. Giornale Italiano di Chemioterapia 1988;35(1-3):69-73. [MEDLINE: 3256513]
159. Tulli A, Leone E, De Simone C. 1% tioconazole powder in the treatment of dermatomycoses [Il tioconazole 1% nel trattamento delle dermatomicosi]. La Clinica Terapeutica 1988;126(6):417-20. [MEDLINE: 2974403]
160. Wiedey K, Renovanz H-D, Maier-Lenz H. Comparative study of therapeutic effectiveness of tolciclate and miconazole in superficial dermatophytosis and in pityriasis versicolor [Vergleichsuntersuchungen zwischen Tolciclat und Miconazolbei oberflächlichen Dermatophytien und Pityriasis versicolor]. Mykosen 1982;25(3):126-32. [MEDLINE: 7045655]
161. Alomar A, Videla S, Delgadillo J, Gich I, Izquierdo I, Forn J, et al.Flutrimazole 1% dermal cream in the treatment of dermatomycoses: a multicentre, double-blind, randomized, comparative clinical trial with bifonazole 1% cream. Efficacy of flutrimazole 1% dermal cream in dermatomycoses. Catalan Flutrimazole Study Group. Dermatology 1995;190(4):295-300. [EMBASE: 1995164602]
162. Binet O, Soto-Melo J, Delgadillo J, Videla S, Izquierdo I, Forn J, et al.Flutrimazole 1% dermal cream in the treatment of dermatomycosis: a randomized, multicentre, double-blind, comparative clinical trial with 1% clotrimazole cream. Flutrimazole Study Group [Flutrimazol-Creme (1%) zur Behandlung von Dermatomykosen: Eine randomisierte, multizentrische, gegen Clotrimazol-Creme (1%) im Vergleich durchgeführte Doppelblindstudie]. Mycoses 1994;37(11-12):455-59. [EMBASE: 1995163523]
163. Choudhary S, Bisati S, Singh A, Koley S. Efficacy and safety of terbinafine hydrochloride 1% cream vs. sertaconazole nitrate 2% cream in tinea corporis and tinea cruris: a comparative therapeutic trial. Indian Journal of Dermatology 2013;58(6):457-60. [PUBMED: PMID: 24249898 ]
164. Darouti MA, al Raubaie S, Shandrashekhar CR, al Sawaf MH, Movahadi GA. Double-blind randomized comparative study of naftifine cream and clotrimazole cream in the treatment of dermatophytosis. International Journal of Dermatology 1989;28(5):345-6. [EMBASE: 1989179688]
165. Fredriksson T. Topical treatment of superficial mycoses with clotrimazole. Postgraduate Medical Journal 1974;50(Suppl 1):62-4. [EMBASE: 0975076502]
166. Gooskens V, Pönnighaus JM, Clayton Y, Mkandawire P, Sterne JA. Treatment of superficial mycoses in the tropics: Whitfield's ointment versus clotrimazole. International Journal of Dermatology 1994;33(10):738-42. [EMBASE: 1994316701]
167. Jones TM, Jarratt MT, Mendez-Moguel I, Paz N, Grekin SK, Cognata Smith C, et al.A randomized, multicenter, double-blind, vehicle-controlled study evaluating the efficacy and safety of luliconazole cream 1% once daily for 7 days in patients aged ≥ 12 years with tinea cruris. Journal of Drugs in Dermatology 2014;13(1):32-8. [PUBMED: PMID: 24385117]
168. Jones TM, Smith CC, Kaur M, Jarett MT, Grekin SK. A randomized, multicenter, double-blind, vehicle-controlled study evaluating the efficacy and safety of luliconazole cream 1% once daily for 7 days in adults with tinea cruris. Journal of the American Academy of Dermatology 2014;70(5):AB107.
169. Kuokkanen K. Topical tioconazole in dermatomycosis [Lokalbehandlung mit Tioconazol bei Dermatomykosen]. Mykosen 1982;25(5):274-80. [EMBASE: 1982139681]
170. Male O. Comparison of naftifine with clotrimazole and tolnaftate in patients with superficial dermatophytoses. Current chemotherapy and immunotherapy. Proceedings of the 12th International Congress of Chemotherapy, Washington, DC: American Society of Microbiology. 1981:1019-1021.
171. Nolting S, Rogalla K. Double-blind comparison of miconazole/corticosteroid combination versus miconazole in inflammatory dermatomycoses. International Journal of Dermatology 1995;34(2):125-8. [EMBASE: 1995050973]
172. Tamil Selvan A, Girisha G, Vijaybhaskar, Suthakaran R. Comparative evaluation of newer topical antifungal agents in the treatment of superficial fungal infections (tinea or dermatophytic). International Research Journal of Pharmacy 2013;4(6):224-8. [EMBASE: 2013588560]
173. Thaker SJ, Mehta DS, Shah HA, Dave JN, Mundhava SG. A comparative randomized open label study to evaluate efficacy, safety and cost effectiveness between topical 2% sertaconazole and topical 1% butenafine in tinea infections of skin. Indian Journal of Dermatology 2013;58(6):451-6. [PUBMED: PMID: 24249897]
174. CTRI/2009/091/000679. A clinical trial to study the effects of two drugs, naftifine and terbinafine in patients with dermatophytosis. www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=867 (accessed 1 June 2014).
175. CTRI/2009/091/001025. A clinical trial in patients with Tinea pedis and Tinea cruris. Clinical trial is to study efficacy, safety and tolerability of Naftifine Hydrochloride 1% cream in comparison to Terbinafine Hydrochloride 1% cream (reference product). www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=1161 (accessed 1 June 2014).
176. CTRI/2010/091/000178. A clinical trial to study the effect of a fixed dose formulation of Sertaconazole + Beclomethasone and miconazole nitrate in patients with tinea infections associated with inflammatory skin conditions. www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=1391 (accessed 1 June 2014).
177. CTRI/2012/03/002522. A clinical trial to study the effects of drugs Calmagen cream and lotion in patients for topical treatment of Tinea (ringworm infection). www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=2767 (accessed 1 June 2014).
178. EUCTR2005-001239-32. Ensayo clínico multicéntrico, aleatorizado, paralelo, doble ciego, para evaluar la eficacia y seguridad de eberconazol solución 1% frente a placebo en el tratamiento de las dermatofitosis. apps.who.int/trialsearch/trial.aspx?trialid=EUCTR2005-001239-32-ES (accessed 1 June 2014).
179. NCT01342315 Topical Antifungal Treatment for Tinea Cruris. clinicaltrials.gov/show/NCT01342315 (accessed 1 June 2014).
180. NCT01885156. Evaluation of Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris. http://clinicaltrials.gov/show/NCT01885156 (accessed 23 May 2014).
181. Alston SJ, Cohen BA, Braun M. Persistent and recurrent tinea corporis in children treated with combination antifungal/corticosteroid agents. Pediatrics 2003;111(1):201-3. [MEDLINE: 12509578]
182. Aly R. Ecology and epidemiology of dermatophyte infections. Journal of the American Academy of Dermatology 1994;31(3 Pt 2):S21-5. [MEDLINE: 8077503]
183. Ameen M. Epidemiology of superficial fungal infections. Clinics in Dermatology 2010;28(2):197-201. [MEDLINE: 20347663]
184. Andrews MD, Burns M. Common tinea infections in children. American Family Physician 2008;77(10):1415-20. [MEDLINE: 18533375]
185. Aridogan IA, Ates A, Izol V, Ilkit M. Tinea cruris in routine urology practice. Urologia Internationalis 2005;74(4):346-8. [MEDLINE: 15897702]
186. Balci DD, Cetin M. Widespread, chronic, and fluconazole-resistant Trichophyton rubrum infection in an immunocompetent patient. Mycoses 2008;51(6):546-8. [MEDLINE: 18422918]
187. Barkey WF. Striae and persistent tinea corporis related to prolonged use of betamethasone dipropionate 0.05% cream/clotrimazole 1% cream (Lotrisone cream). Journal of the American Academy of Dermatology 1987;17(3):518-9. [MEDLINE: 3655035]
188. Bassiri-Jahromi S, Khaksari AA. Epidemiological survey of dermatophytosis in Tehran, Iran, from 2000 to 2005. Indian Journal of Dermatology, Venereology & Leprology 2009;75(2):142-7. [MEDLINE: 19293500]
189. Bell-Syer SE, Hart R, Crawford F, Torgerson DJ, Tyrrell W, Russell I. Oral treatments for fungal infections of the skin of the foot. Cochrane Database of Systematic Reviews 2002, Issue 2. [DOI: 10.1002/14651858.CD003584]
190. Brasch J. Pathogenesis of tinea. Journal der Deutschen Dermatologischen Gesellschaft 2010;8(10):780-6. [MEDLINE: 20678152]
191. Brown P, Brunnhuber K, Chalkidou K, Chalmers I, Clarke M, Fenton M, et al.How to formulate research recommendations. BMJ 2006;333(7572):804-6. [MEDLINE: 17038740]
192. Crawford F, Hollis S. Topical treatments for fungal infections of the skin and nails of the foot. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD001434.pub2]
193. Curtin F, Elbourne D, Altman DG. Meta-analysis combining parallel and cross-over clinical trials. II: Binary outcomes. Statistics in Medicine 2002;21(15):2145-59. [MEDLINE: 12210630]
194. Darkes MJ, Scott LJ, Goa KL. Terbinafine: a review of its use in onychomycosis in adults. American Journal of Clinical Dermatology 2003;4(1):39-65. [MEDLINE: 12477372]
195. Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hardinsky MK, et al.Guidelines of care for superficial mycotic infections of the skin: tinea corporis, tinea cruris, tinea faciei, tinea manuum, and tinea pedis. Guidelines/Outcomes Committee. American Academy of Dermatology. Journal of the American Academy of Dermatology 1996;34(2 Pt 1):282-6. [MEDLINE: 8642094]
196. El-Gohary M, Burgess H, Doney L, Johnson E, Stuart B, Moore M, et al.Topical antifungal treatments for tinea cruris and tinea corporis. Cochrane Database of Systematic Reviews 2012, Issue 8. [DOI: 10.1002/14651858.CD009992]
197. Erbagci Z. Topical therapy for dermatophytoses: should corticosteroids be included?. American Journal of Clinical Dermatology 2004;5(6):375-84. [MEDLINE: 15663334]
198. Fedorowicz Z, van Zuuren EJ. Efficacy of topical antifungals in the treatment of dermatophytosis: an incomplete meta-analysis. JAMA Dermatology 2013;149(10):1243-4.
199. Fergusson D, Aaron SD, Guyatt G, Hébert P. Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. BMJ 2002;325(7365):652-4. [PUBMED: 12242181]
200. Fox GN. 10 derm mistakes you don't want to make. Journal of Family Practice 2008;57(3):162-9. [MEDLINE: 18321452]
201. Ghannoum MA, Rice LB. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clinical Microbiology Reviews 1999;12(4):501-17. [MEDLINE: 10515900]
202. Goldstein AO, Goldstein BG. Dermatophyte (tinea) infections. www.uptodate.com/contents/dermatophyte-tinea-infections, website (accessed 7 September 2013).
203. Gonzalez U, Seaton T, Bergus G, Jacobson J, Martinez-Monzon C. Systemic antifungal therapy for tinea capitis in children. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD004685.pub2]
204. Greenberg HL, Shwayder TA, Bieszk N, Fivenson DP. Clotrimazole/betamethasone diproprionate: a review of costs and complications in the treatment of common cutaneous fungal infections. Pediatric Dermatology 2002;19(1):78-81. [MEDLINE: 11860579]
205. Grudzien M, Krol A, Paterek G, Stepien K, Plucinski F, Mazurek AP. The structure-bioavailability approach in antifungal agents. European Journal of Medicinal Chemistry 2009;44(5):1978-81. [MEDLINE: 19062137]
206. Gupta AK, Chaudhry M, Elewski B. Tinea corporis, tinea cruris, tinea nigra, and piedra. Dermatologic Clinics 2003;21(3):395-400, v. [MEDLINE: 12956194]
207. Gupta AK, Cooper EA, Ryder JE, Nicol KA, Chow M, Chaudhry MM. Optimal management of fungal infections of the skin, hair, and nails. American Journal of Clinical Dermatology 2004;5(4):225-37. [MEDLINE: 15301570]
208. Gupta AK, Cooper EA. Update in antifungal therapy of dermatophytosis. Mycopathologia 2008;166(5-6):353-67. [MEDLINE: 18478357]
209. Hainer BL. Dermatophyte infections. American Family Physician 2003;67(1):101-8. [MEDLINE: 12537173]
210. Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses 2008;51 Suppl 4:2-15. [MEDLINE: 18783559]
211. Havlickova B, Friedrich M. The advantages of topical combination therapy in the treatment of inflammatory dermatomycoses. Mycoses 2008;51(Suppl 4):16-26. [MEDLINE: 18783560]
212. Herbison P, Hay-Smith J, Gillespie WJ. Adjustment of meta-analyses on the basis of quality scores should be abandoned. Journal of Clinical Epidemiology 2006;59(12):1249-56. [MEDLINE: 17098567]
213. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
214. ICH Expert Working Group. Statistical principles for clinical trials E9. www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E9/Step4/E9_Guideline.pdf 5 February 1998.
215. Jain A, Jain S, Rawat S. Emerging fungal infections among children: A review on its clinical manifestations, diagnosis, and prevention. Journal of Pharmacy and Bioallied Sciences 2010;2(4):314-20. [MEDLINE: 21180463]
216. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003;326(7400):1167-70. [MEDLINE: 12775614]
217. Macura AB. Dermatophyte infections. International Journal of Dermatology 1993;32(5):313-23. [MEDLINE: 8505155]
218. Moriarty B, Hay R, Morris-Jones R. The diagnosis and management of tinea. BMJ 2012;345:e4380. [MEDLINE: 22782730]
219. Nadalo D, Montoya C, Hunter-Smith D. What is the best way to treat tinea cruris?. Journal of Family Practice 2006;55(3):256-8. [MEDLINE: 16510062]
220. Noble SL, Forbes RC, Stamm PL. Diagnosis and management of common tinea infections. American Family Physician 1998;58(1):163-78. [MEDLINE: 9672436]
221. Olivo SA, Macedo LG, Gadotti IC, Fuentes J, Stanton T, Magee DJ. Scales to assess the quality of randomized controlled trials: a systematic review. Physical Therapy 2008;88(2):156-75. [MEDLINE: 18073267]
222. Reynolds RD, Boiko S, Lucky AW. Exacerbation of tinea corporis during treatment with 1% clotrimazole/0.05% betamethasone diproprionate (Lotrisone). American Journal of Diseases of Children 1991;145(11):1224-5. [MEDLINE: 1951207]
223. Rosen T, Elewski BE. Failure of clotrimazole-betamethasone dipropionate cream in treatment of Microsporum canis infections. Journal of the American Academy of Dermatology 1995;32(6):1050-1. [MEDLINE: 7751452]
224. Rotta I, Sanchez A, Gonçalves PR, Otuki MF, Correr CJ. Efficacy and safety of topical antifungals in the treatment of dermatomycosis: a systematic review. British Journal of Dermatology 2012;166(5):927-33. [MEDLINE: 22233283]
225. Rotta I, Otuki MF, Sanches AC, Correr CJ. Efficacy of topical antifungal drugs in different dermatomycoses: a systematic review with meta-analysis. Revista da Associacao Medica Brasileira 2012;58(3):308-18. [MEDLINE: 22735222]
226. Rotta I, Ziegelmann PK, Otuki MF, Riveros BS, Bernardo NL, Correr CJ. Efficacy of topical antifungals in the treatment of dermatophytosis: a mixed-treatment comparison meta-analysis involving 14 treatments. JAMA Dermatology 2013;149(3):341-9. [MEDLINE: 23553036]
227. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-12. [MEDLINE: 7823387]
228. Seebacher C, Bouchara JP, Mignon B. Updates on the epidemiology of dermatophyte infections. Mycopathologia 2008;166(5-6):335-52. [MEDLINE: 18478365]
229. Smijs TG, Pavel S. The susceptibility of dermatophytes to photodynamic treatment with special focus on Trichophyton rubrum. Photochemistry & Photobiology 2011;87(1):2-13. [MEDLINE: 21114670]
230. Smith ES, Fleischer AB Jr, Feldman SR. Nondermatologists are more likely than dermatologists to prescribe antifungal/corticosteroid products: an analysis of office visits for cutaneous fungal infections, 1990-1994. Journal of the American Academy of Dermatology 1998;39(1):43-7. [MEDLINE: 9674396]
231. van Zuuren EJ, Fedorowicz Z, Carter B, Andriolo RB, Schoones J. Interventions for female pattern hair loss. Cochrane Database of Systematic Reviews 2012, Issue 5. [DOI: 10.1002/14651858.CD007628]
232. Wacker J, Durani BK, Hartschuh W. Bizarre annular lesion emerging as tinea incognito. Mycoses 2004;47(9-10):447-9. [MEDLINE: 15504132]
233. Weinberg JM. Increasing patient adherence in antifungal infection treatment: once-daily dosing of sertaconazole. Journal of Clinical & Aesthetical Dermatology 2009;2(2):38-42. [MEDLINE: 20967180]
234. Weinstein A, Berman B. Topical treatment of common superficial tinea infections. American Family Physician 2002;65(10):2095-102. [MEDLINE: 12046779]
235. Weitzman I, Summerbell RC. The dermatophytes. Clinical Microbiology Reviews 1995;8(2):240-59. [MEDLINE: 7621400]